Fibrocalculous Pancreatic Diabetes (FCPD): A Rare Type of Pancreatogenic Diabetes
DOI:
https://doi.org/10.66266/inajemd.v2i2.68Keywords:
Fibrocalculous Pancreatic Diabetes, Diabetes Mellitus, Chronic PancreatitisAbstract
Background: FCPD is a rare form of secondary diabetes. FCPD is mainly found in the tropical region; it is characterized by diabetes, chronic abdominal pain, calcification of the pancreas, and steatorrhea. The Incidence of FCPD is often misdiagnosed with type 2 or type 1 diabetes mellitus.
Case Illustration: A 46-year-old man came with chief complaints of chronic abdominal pain. Abdominal radiography showed calcification in the pancreas. The patient was malnourished. Abdominal X-ray revealed pancreatic calcification, which was confirmed by an abdominal MSCT scan. C-Peptide decreased with an intermediate degree. The patient was given supportive therapy,
and insulin was given to control his diabetes.
Discussion: FCPD is a morphological pancreas change caused by chronic tropical pancreatitis. The aetiology of chronic tropical pancreatitis is unknown. FCPD can be diagnosed by history taking and supporting examinations such as abdominal X-ray examination, ultrasound and abdominal CT Scan. C-peptide was examined to assess the function of pancreatic beta cells. The primary treatment for FCPD is insulin therapy; metformin or Sulfonylureas can be used in the early phase of diabetes. In reducing pain, non-steroidal analgesics are used as an option. The use of pancreatic enzyme supplementation can improve the nutritional status of patients.
Conclusion. FCPD is a rare case, occurring mainly in tropical countries and in people who are malnourished. The primary treatment for FCPD is insulin therapy.
Downloads
References
1. Kumaran S, Unnikrishnan AG. Fibrocalculous
pancreatic diabetes. J Diabetes Complications.
2021;35(1):1–7.
2. Aiswarya Y, Shivaprasad C, Anish K, Sridevi
A, Anupam B, Amit G. Assessment of insulin
sensitivity and secretion in patients with
fibrocalculous pancreatic diabetes. Diabetes,
Metab Syndr Obes Targets Ther. 2019;12:779–88.
3. Praveen G, Mohan V. Fibrocalculous
pancreatic diabetes — current scenario in
developing countries. Int J Diabetes Dev Ctries.
2018;38(2):131–2.
4. Unnikrishnan R, Mohan V. Fibrocalculous
pancreatic diabetes (FCPD). Acta Diabetol.
2015;52(1):1–9.
5. Barman KK, Premalatha G, Mohan V. Tropical
chronic pancreatitis. Postgr Med J. 2003;79:606–
15.
6. Chowdhury Z, Mcdermott MF, Davey S,
Hassan Z, Sinnott PJ, Hemmatpour SK. Genetic
susceptibility to fibrocalculous pancreatic
diabetes in Bangladeshi subjects: a family study.
Genes Immun. 2002;3:5–8.
7. Ralapanawa DMP, Jayawickreme K poornima,
Ekanayake EM. Fibrocalculous pancreatic
diabetes : a case report. BMC Res Notes.
2015;8:175.
8. Shivaprasad C, Anish K, Aiswarya Y, Atluri S,
Rakesh B, Anupam B, et al. A comparative
study of the clinical profile of fibrocalculous
pancreatic diabetes and type 2 diabetes mellitus.
Diabetes Metab Syndr Clin Res Rev [Internet].
2019;13(2):1511–6. Available from: https://doi.
org/10.1016/j.dsx.2019.03.003
9. Singh V, Tandon MS. Fibrocalculous Pancreatic
Diabetes in a Young Female : A Case Report from
South Gujarat. J Diabetol. 2019;10:140–2.
10. Bhat J, Bhat MH, Misgar R, Bashir M, Wani
A, Masoodi S, et al. The clinical spectrum of
fibrocalculous pancreatic diabetes in Kashmir
valley and comparative study of the clinical
profile of fibrocalculous pancreatic diabetes
and type 2 diabetes mellitus. Indian J Endocrinol
Metab. 2019;23(5):580–4.
11. Dasgupta R, Naik D, Thomas N. Emerging
concepts in the pathogenesis of diabetes in
fibrocalculous pancreatic diabetes. J Diabetes.
2015;7(6):754–61.
12. Xia F, Zhou W, Wang B, Hu Y. Non-tropical
fibrocalculous pancreatic diabetes: case reports
and review of recent literature. J Int Med Res.
2020;48(7).
13. Bavuma C, Sahabandu D, Musafiri S, Danquah I,
McQuillan R, Wild S. Atypical forms of diabetes
mellitus in Africans and other non-European
ethnic populations in low- and middle-income
countries: a systematic literature review. J Glob
Health. 2019;9(2):020401.
14. Ghosh I, Mukhopadhyay P, Das K, Anne M
B, Ali Mondal S, Basu M, et al. Incretins in
fibrocalculous pancreatic diabetes: A unique
subtype of pancreatogenic diabetes. J Diabetes.
2020;1–6.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 InaJEMD - Indonesian Journal of Endocrinology Metabolic and Diabetes

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain copyright and grant the Indonesian Journal of Endocrinology, Metabolism and Diabetes (InaJEMD) the right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
© Indonesian Journal of Endocrinology, Metabolism and Diabetes (InaJEMD). Published by the Indonesian Society of Endocrinology (PERKENI).


